Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02796820Phase 3Unknown
Phase 3, randomised, open-label trial in colorectal cancer (CRC) comparing Huaier Granule with Regular follow-up observation (2 arms). Primary endpoint: Disease-free survival at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02796820.